These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 27134145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
    Tepeš B, Vujasinović M, Šeruga M, Stefanovič M, Forte A, Jeverica S.
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):676-83. PubMed ID: 26862930
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F.
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [Abstract] [Full Text] [Related]

  • 4. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J, Pazos-Pacheco C, Vinagre-Rodriguez G, Perez-Gallardo B, Dueñas-Sadornil C, Hernandez-Alonso M, Gonzalez-Garcia G, Mateos-Rodriguez JM, Fernandez-Bermejo M, Gisbert JP.
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
    McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio J, Ducons J, Calvet X, de la Coba C, Montoro M, Bory F, Perez-Aisa A, Forné M, Gisbert JP, Participant Centres.
    Gut; 2014 Feb; 63(2):244-9. PubMed ID: 23665990
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, Lee SM, Hahm KB, Lee SM, Jeong JY, Yun SC.
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [Abstract] [Full Text] [Related]

  • 10. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
    Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Peña R, Peña EM, Salazar-Martínez E, Correa P, Martínez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH.
    Lancet; 2011 Aug 06; 378(9790):507-14. PubMed ID: 21777974
    [Abstract] [Full Text] [Related]

  • 11. Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Long X, Chen Q, Yu L, Liang X, Liu W, Lu H.
    Helicobacter; 2018 Jun 06; 23(3):e12485. PubMed ID: 29696736
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
    Abuhammour A, Dajani A, Nounou M, Zakaria M.
    Arab J Gastroenterol; 2016 Sep 06; 17(3):131-136. PubMed ID: 27665525
    [Abstract] [Full Text] [Related]

  • 15. Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
    Apostolopoulos P, Koumoutsos I, Ekmektzoglou K, Dogantzis P, Vlachou E, Kalantzis C, Tsibouris P, Alexandrakis G.
    Scand J Gastroenterol; 2016 Sep 06; 51(2):145-51. PubMed ID: 26435055
    [Abstract] [Full Text] [Related]

  • 16. Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth.
    Akpinar Z, Akay S, Unsal B.
    Arab J Gastroenterol; 2017 Jun 06; 18(2):58-61. PubMed ID: 28532623
    [Abstract] [Full Text] [Related]

  • 17. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A, Scaccianoce G, De Francesco V, Ruggiero V, D'Ambrosio P, Castorani L, Bonfrate L, Vannella L, Hassan C, Portincasa P.
    Clin Res Hepatol Gastroenterol; 2013 Dec 06; 37(6):647-50. PubMed ID: 23747131
    [Abstract] [Full Text] [Related]

  • 18. [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
    Campillo A, Amorena E, Ostiz M, Kutz M, LaIglesia M.
    Gastroenterol Hepatol; 2016 Nov 06; 39(9):584-589. PubMed ID: 27084668
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.